Literature DB >> 19436109

A partial form of recessive STAT1 deficiency in humans.

Ariane Chapgier1, Xiao-Fei Kong, Stéphanie Boisson-Dupuis, Emmanuelle Jouanguy, Diana Averbuch, Jacqueline Feinberg, Shen-Ying Zhang, Jacinta Bustamante, Guillaume Vogt, Julien Lejeune, Eleonore Mayola, Ludovic de Beaucoudrey, Laurent Abel, Dan Engelhard, Jean-Laurent Casanova.   

Abstract

Complete STAT1 deficiency is an autosomal recessive primary immunodeficiency caused by null mutations that abolish STAT1-dependent cellular responses to both IFN-alpha/beta and IFN-gamma. Affected children suffer from lethal intracellular bacterial and viral diseases. Here we report a recessive form of partial STAT1 deficiency, characterized by impaired but not abolished IFN-alpha/beta and IFN-gamma signaling. Two affected siblings suffered from severe but curable intracellular bacterial and viral diseases. Both were homozygous for a missense STAT1 mutation: g.C2086T (P696S). This STAT1 allele impaired the splicing of STAT1 mRNA, probably by disrupting an exonic splice enhancer. The misspliced forms were not translated into a mature protein. The allele was hypofunctional, because residual full-length mRNA production resulted in low but detectable levels of normally functional STAT1 proteins. The P696S amino acid substitution was not detrimental. The patients' cells, therefore, displayed impaired but not abolished responses to both IFN-alpha and IFN-gamma. We also show that recessive STAT1 deficiencies impaired the IL-27 and IFN-lambda1 signaling pathways, possibly contributing to the predisposition to bacterial and viral infections, respectively. Partial recessive STAT1 deficiency is what we believe to be a novel primary immunodeficiency, resulting in impairment of the response to at least 4 cytokines (IFN-alpha/beta, IFN-gamma, IFN-lambda1, and IL-27). It should be considered in patients with unexplained, severe, but curable intracellular bacterial and viral infections.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19436109      PMCID: PMC2689115          DOI: 10.1172/JCI37083

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  50 in total

1.  Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA.

Authors:  X Chen; U Vinkemeier; Y Zhao; D Jeruzalmi; J E Darnell; J Kuriyan
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

2.  Bacillus Calmette Guerin triggers the IL-12/IFN-gamma axis by an IRAK-4- and NEMO-dependent, non-cognate interaction between monocytes, NK, and T lymphocytes.

Authors:  Jacqueline Feinberg; Claire Fieschi; Rainer Doffinger; Max Feinberg; Tony Leclerc; Stéphanie Boisson-Dupuis; Capucine Picard; Jacinta Bustamante; Ariane Chapgier; Orchidée Filipe-Santos; Cheng-Lung Ku; Ludovic de Beaucoudrey; Janine Reichenbach; Guillemette Antoni; Ramatoulaye Baldé; Alexandre Alcaïs; Jean-Laurent Casanova
Journal:  Eur J Immunol       Date:  2004-11       Impact factor: 5.532

3.  Mycobacterium avium inhibition of IFN-gamma signaling in mouse macrophages: Toll-like receptor 2 stimulation increases expression of dominant-negative STAT1 beta by mRNA stabilization.

Authors:  Gail R Alvarez; Bruce S Zwilling; William P Lafuse
Journal:  J Immunol       Date:  2003-12-15       Impact factor: 5.422

4.  STAT1 knockout mice are highly susceptible to pulmonary mycobacterial infection.

Authors:  Isamu Sugawara; Hiroyuki Yamada; Satoru Mizuno
Journal:  Tohoku J Exp Med       Date:  2004-01       Impact factor: 1.848

5.  STAT2 nuclear trafficking.

Authors:  Gregg Banninger; Nancy C Reich
Journal:  J Biol Chem       Date:  2004-06-01       Impact factor: 5.157

6.  Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway.

Authors:  M A Meraz; J M White; K C Sheehan; E A Bach; S J Rodig; A S Dighe; D H Kaplan; J K Riley; A C Greenlund; D Campbell; K Carver-Moore; R N DuBois; R Clark; M Aguet; R D Schreiber
Journal:  Cell       Date:  1996-02-09       Impact factor: 41.582

7.  Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease.

Authors:  J E Durbin; R Hackenmiller; M C Simon; D E Levy
Journal:  Cell       Date:  1996-02-09       Impact factor: 41.582

8.  A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression.

Authors:  Massimo Caputi; Marcel Freund; Susanne Kammler; Corinna Asang; Heiner Schaal
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

9.  Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling.

Authors:  Laure Dumoutier; Amel Tounsi; Thomas Michiels; Caroline Sommereyns; Sergei V Kotenko; Jean-Christophe Renauld
Journal:  J Biol Chem       Date:  2004-05-27       Impact factor: 5.157

Review 10.  Getting the message across, STAT! Design principles of a molecular signaling circuit.

Authors:  Uwe Vinkemeier
Journal:  J Cell Biol       Date:  2004-10-25       Impact factor: 10.539

View more
  87 in total

1.  STAT1-deficient mice are resistant to cecal ligation and puncture-induced septic shock.

Authors:  Daniela Herzig; Geping Fang; Tracy E Toliver-Kinsky; Yin Guo; Julia Bohannon; Edward R Sherwood
Journal:  Shock       Date:  2012-10       Impact factor: 3.454

Review 2.  Flow Cytometry, a Versatile Tool for Diagnosis and Monitoring of Primary Immunodeficiencies.

Authors:  Roshini S Abraham; Geraldine Aubert
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

Review 3.  Recent insights into the pathobiology of innate immune deficiencies.

Authors:  Sergio D Rosenzweig; Steven M Holland
Journal:  Curr Allergy Asthma Rep       Date:  2011-10       Impact factor: 4.806

Review 4.  The emerging safety profile of JAK inhibitors in rheumatic disease.

Authors:  Kevin L Winthrop
Journal:  Nat Rev Rheumatol       Date:  2017-03-02       Impact factor: 20.543

Review 5.  Incomplete penetrance in primary immunodeficiency: a skeleton in the closet.

Authors:  Conor Gruber; Dusan Bogunovic
Journal:  Hum Genet       Date:  2020-02-17       Impact factor: 4.132

6.  Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I.

Authors:  Anne Puel; Rainer Döffinger; Angels Natividad; Maya Chrabieh; Gabriela Barcenas-Morales; Capucine Picard; Aurélie Cobat; Marie Ouachée-Chardin; Antoine Toulon; Jacinta Bustamante; Saleh Al-Muhsen; Mohammed Al-Owain; Peter D Arkwright; Colm Costigan; Vivienne McConnell; Andrew J Cant; Mario Abinun; Michel Polak; Pierre-François Bougnères; Dinakantha Kumararatne; László Marodi; Amit Nahum; Chaim Roifman; Stéphane Blanche; Alain Fischer; Christine Bodemer; Laurent Abel; Desa Lilic; Jean-Laurent Casanova
Journal:  J Exp Med       Date:  2010-02-01       Impact factor: 14.307

7.  Interferon-alpha induces high expression of APOBEC3G and STAT-1 in vitro and in vivo.

Authors:  Hui Chen; Lu-Wen Wang; Yan-Qing Huang; Zuo-Jiong Gong
Journal:  Int J Mol Sci       Date:  2010-09-20       Impact factor: 5.923

8.  A novel form of cell type-specific partial IFN-gammaR1 deficiency caused by a germ line mutation of the IFNGR1 initiation codon.

Authors:  Xiao-Fei Kong; Guillaume Vogt; Ariane Chapgier; Christophe Lamaze; Jacinta Bustamante; Carolina Prando; Anny Fortin; Anne Puel; Jacqueline Feinberg; Xin-Xin Zhang; Pauline Gonnord; Ulla M Pihkala-Saarinen; Mikko Arola; Petra Moilanen; Laurent Abel; Matti Korppi; Stéphanie Boisson-Dupuis; Jean-Laurent Casanova
Journal:  Hum Mol Genet       Date:  2009-10-31       Impact factor: 6.150

Review 9.  Human Genetic Determinants of Viral Diseases.

Authors:  Adam D Kenney; James A Dowdle; Leonia Bozzacco; Temet M McMichael; Corine St Gelais; Amanda R Panfil; Yan Sun; Larry S Schlesinger; Matthew Z Anderson; Patrick L Green; Carolina B López; Brad R Rosenberg; Li Wu; Jacob S Yount
Journal:  Annu Rev Genet       Date:  2017-08-30       Impact factor: 16.830

10.  B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans.

Authors:  Danielle T Avery; Elissa K Deenick; Cindy S Ma; Santi Suryani; Nicholas Simpson; Gary Y Chew; Tyani D Chan; Umamainthan Palendira; Jacinta Bustamante; Stéphanie Boisson-Dupuis; Sharon Choo; Karl E Bleasel; Jane Peake; Cecile King; Martyn A French; Dan Engelhard; Sami Al-Hajjar; Saleh Al-Muhsen; Klaus Magdorf; Joachim Roesler; Peter D Arkwright; Pravin Hissaria; D Sean Riminton; Melanie Wong; Robert Brink; David A Fulcher; Jean-Laurent Casanova; Matthew C Cook; Stuart G Tangye
Journal:  J Exp Med       Date:  2010-01-04       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.